gastroparesis and glp 1 glp-1 class action in west virginia Safety Tolerability of Glucagon-Like Peptide-1 GASTROPARESIS RISK IN PATIENTS WITH – How should long‑term gastroparesis caused

Common symptoms Fewer than three bowel movements per week Hard, dry, or lumpy stools Straining during bowel movements Sensation of incomplete emptying of bowels Abdominal discomfort, bloating, or cramping Feeling of fullness or pressure in the rectum Possible nausea or reduced appetite How common is constipation with GLP-1 treatments

It has a 3.7-star rating with over 3,000 reviews

S2CID 19887643

doi: 10.1093/toxsci/kfw158 29 EakinsR.WalshJ.RandleL.JenkinsR

Increased blood glucose Reported specifically in people with diabetes

In many ways, microdosing GLP-1s reflects a broader shift away from one-size-fits-all dosing and toward individualized care